These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

328 related articles for article (PubMed ID: 16158070)

  • 1. Nanoparticle-induced platelet aggregation and vascular thrombosis.
    Radomski A; Jurasz P; Alonso-Escolano D; Drews M; Morandi M; Malinski T; Radomski MW
    Br J Pharmacol; 2005 Nov; 146(6):882-93. PubMed ID: 16158070
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Role of von Willebrand factor in tumour cell-induced platelet aggregation: differential regulation by NO and prostacyclin.
    Jurasz P; Stewart MW; Radomski A; Khadour F; Duszyk M; Radomski MW
    Br J Pharmacol; 2001 Nov; 134(5):1104-12. PubMed ID: 11682459
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Incomplete inhibition of platelet aggregation and glycoprotein IIb-IIIa receptor blockade by abciximab: importance of internal pool of glycoprotein IIb-IIIa receptors.
    Gawaz M; Ruf A; Pogatsa-Murray G; Dickfeld T; Rüdiger S; Taubitz W; Fischer J; Müller I; Meier D; Patscheke H; Schömig A
    Thromb Haemost; 2000 Jun; 83(6):915-22. PubMed ID: 10896249
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Temporal and pharmacological characterization of angiostatin release and generation by human platelets: implications for endothelial cell migration.
    Radziwon-Balicka A; Moncada de la Rosa C; Zielnik B; Doroszko A; Jurasz P
    PLoS One; 2013; 8(3):e59281. PubMed ID: 23555012
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Platelet compatibility of PLGA, chitosan and PLGA-chitosan nanoparticles.
    Li X; Radomski A; Corrigan OI; Tajber L; De Sousa Menezes F; Endter S; Medina C; Radomski MW
    Nanomedicine (Lond); 2009 Oct; 4(7):735-46. PubMed ID: 19839810
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Matrix metalloproteinase 2 in tumor cell-induced platelet aggregation: regulation by nitric oxide.
    Jurasz P; Sawicki G; Duszyk M; Sawicka J; Miranda C; Mayers I; Radomski MW
    Cancer Res; 2001 Jan; 61(1):376-82. PubMed ID: 11196190
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Deubiquitinases Modulate Platelet Proteome Ubiquitination, Aggregation, and Thrombosis.
    Gupta N; Li W; McIntyre TM
    Arterioscler Thromb Vasc Biol; 2015 Dec; 35(12):2657-66. PubMed ID: 26471267
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Combined effects of a factor Xa inhibitor YM466 and a GPIIb/IIIa antagonist YM128 on thrombosis and neointima formation in mice.
    Iwatsuki Y; Kawasaki T; Hayashi K; Moritani Y; Nii T; Miyata K
    Thromb Haemost; 2004 Dec; 92(6):1221-8. PubMed ID: 15583727
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Extracellular cyclophilin A activates platelets via EMMPRIN (CD147) and PI3K/Akt signaling, which promotes platelet adhesion and thrombus formation in vitro and in vivo.
    Seizer P; Ungern-Sternberg SN; Schönberger T; Borst O; Münzer P; Schmidt EM; Mack AF; Heinzmann D; Chatterjee M; Langer H; Malešević M; Lang F; Gawaz M; Fischer G; May AE
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):655-63. PubMed ID: 25550208
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Platelet aggregation-induced by caco-2 cells: regulation by matrix metalloproteinase-2 and adenosine diphosphate.
    Medina C; Jurasz P; Santos-Martinez MJ; Jeong SS; Mitsky T; Chen R; Radomski MW
    J Pharmacol Exp Ther; 2006 May; 317(2):739-45. PubMed ID: 16424148
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevention of platelet glycoprotein IIb/IIIa activation by 3,4-methylenedioxy-beta-nitrostyrene, a novel tyrosine kinase inhibitor.
    Wang WY; Wu YC; Wu CC
    Mol Pharmacol; 2006 Oct; 70(4):1380-9. PubMed ID: 16837624
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Effects of functionalized silver nanoparticles on aggregation of human blood platelets.
    Hajtuch J; Hante N; Tomczyk E; Wojcik M; Radomski MW; Santos-Martinez MJ; Inkielewicz-Stepniak I
    Int J Nanomedicine; 2019; 14():7399-7417. PubMed ID: 31571858
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of platelet-mediated arterial thrombosis and platelet granule exocytosis by 3',4'-dihydroxyflavonol and quercetin.
    Mosawy S; Jackson DE; Woodman OL; Linden MD
    Platelets; 2013; 24(8):594-604. PubMed ID: 23249183
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The fibrinogen gamma chain dodecapeptide inhibits agonist-induced aggregation of rabbit platelets and fibrinogen binding to rabbit glycoprotein IIb-IIIa.
    Rand ML; Packham MA; Taylor DM; Yeo EL; Gemmell CH; Patil S; Lam SC
    Thromb Haemost; 1999 Dec; 82(6):1680-6. PubMed ID: 10613655
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Conformation-specific blockade of the integrin GPIIb/IIIa: a novel antiplatelet strategy that selectively targets activated platelets.
    Schwarz M; Meade G; Stoll P; Ylanne J; Bassler N; Chen YC; Hagemeyer CE; Ahrens I; Moran N; Kenny D; Fitzgerald D; Bode C; Peter K
    Circ Res; 2006 Jul; 99(1):25-33. PubMed ID: 16778135
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Glycoprotein IIb/IIIa inhibition enhances platelet nitric oxide release.
    Chakrabarti S; Clutton P; Varghese S; Cox D; Mascelli MA; Freedman JE
    Thromb Res; 2004; 113(3-4):225-33. PubMed ID: 15140587
    [TBL] [Abstract][Full Text] [Related]  

  • 17. FcgammaRII mediates platelet aggregation caused by disintegrins and GPIIb/IIIa monoclonal antibody, AP2.
    Huang TF; Chang CH; Ho PL; Chung CH
    Exp Hematol; 2008 Dec; 36(12):1704-13. PubMed ID: 18809237
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A highly constrained cyclic (S,S)-CDC- peptide is a potent inhibitor of carotid artery thrombosis in rabbits.
    Roussa VD; Stathopoulou EM; Papamichael ND; Englezopoulos CV; Rousouli KI; Trypou P; Moussis V; Tellis CC; Katsouras CS; Tsikaris V; Tselepis AD; Michalis LK
    Platelets; 2011; 22(5):361-70. PubMed ID: 21158497
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Characterization of a novel function-blocking antibody targeted against the platelet P2Y1 receptor.
    Karim ZA; Vemana HP; Alshbool FZ; Lin OA; Alshehri AM; Javaherizadeh P; Paez Espinosa EV; Khasawneh FT
    Arterioscler Thromb Vasc Biol; 2015 Mar; 35(3):637-44. PubMed ID: 25593131
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ethanol enhances the inhibitory effect of an oral GPIIb/IIIa antagonist on human platelet function.
    Rand ML; Jakubowski JA; Fisher MJ; Chahil A; Kinlough-Rathbone RL; Packham MA
    J Lab Clin Med; 2002 Dec; 140(6):391-7. PubMed ID: 12486406
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.